Mutations to the spike protein of the omicron variant are shown to alter how the virus infects cells and reduce its sensitivity to therapeutic and vaccine-elicited antibodies, according to a paper published in Nature. Booster ...
Feb 3, 2022
0
35
Researchers at the University of Missouri and the University of Minnesota have discovered how HIV evades one of the body's best defenses—and their collaborative work could offer hope for future treatments that stop the ...
Jan 27, 2022
0
60
Back around Thanksgiving, many families—older members newly boosted and young children freshly vaccinated—felt comfortable gathering to celebrate. Fast forward a month, and some of those winter celebrations took on a ...
Jan 12, 2022
0
1
Efforts to contain the spread of SARS-CoV-2 may benefit from a new analytical tool developed by a team led by biologists at Boston College, who report their computer simulation of molecular interactions can predict mutations ...
Jan 6, 2022
0
17
Researchers from the Chinese Academy of Sciences in Beijing recently reported intriguing new evidence for a possible mouse origin of the Omicron variant. Their paper, posted on the BioRxiv preprint server, was quickly picked ...
WEHI researchers have discovered how dormant Toxoplasma parasites in the brain manipulate their host cells to ensure their own survival.
Dec 21, 2021
0
142
Using the same approach they recently used to create effective vaccine candidates against COVID-19 and respiratory syncytial virus (RSV), scientists are tackling another virus: the tick-borne Crimean-Congo hemorrhagic fever ...
Nov 18, 2021
0
75
Researchers at the National Institutes of Health have discovered a therapy that targets host cells rather than bacterial cells in treating bacterial pneumonia in rodents. The method involves white blood cells of the immune ...
Nov 15, 2021
0
64
Rutgers researchers studying COVID-19 have created a new way to deliver DNA molecules into skin cells, using a suction technique similar to the ancient healing practice of cupping.
Nov 5, 2021
0
62
When it comes to the design of a novel vaccine against viral infection, vaccine developers have to make several major decisions. One of them is the choice of what type of immune response they wish to induce.
Oct 27, 2021
0
28
